Thu 2 Sep 2021
On-demand
On-demand: featuring presentation and speaker Q&A: Supported by Abbott this crucial webinar is designed to cement your learning and enhance your knowledge for interpreting Flash Glucose Monitoring data.
Please note, this event is designed for use by NHS Healthcare Professionals only. If you would like to access this webinar, please email bookings@sbk-healthcare.co.uk and we will send you the link to view.
A full list of all upcoming Diabetes events can also be viewed at the official Diabetes National Networking Forum website.
On-demand
1 hour CPD
Free
1 hour Continuing Professional Development: what you will learn
If you are a HCP that has an existing knowledge of Flash Glucose Monitoring but work with less than 10 downloads a week, this online training is perfect for you. Find out how to:
Designed to cement your learning and enhance your knowledge
|
1 hour video | Filmed on Thursday 2nd September | featuring:
|
|
|
Chair’s opening remarks
Fiona Campbell, Lead Clinician for Paediatrics, Leeds Teaching Hospitals NHS Trust
|
|
|
Intermediate data interpretation for Flash Glucose Monitoring
Ramzi Ajjan, Professor of Metabolic Medicine, University of Leeds and Iain Cranston, Consultant Physician (Diabetes & Endocrinology), Portsmouth Hospitals NHS Trust
|
|
|
Questions and answers with Fiona, Ramzin and Iain
Fiona Campbell, Lead Clinician for Paediatrics, Leeds Teaching Hospitals NHS Trust, Ramzi Ajjan, Professor of Metabolic Medicine, University of Leeds & Iain Cranston, Consultant Physician (Diabetes & Endocrinology), Portsmouth Hospitals NHS Trust
|
First-hand speaker experience
Job Title:
Lead Clinician for Paediatrics
Organisation
Leeds Teaching Hospitals NHS Trust
Biography
Dr Campbell has been a Consultant in Paediatric Diabetes for 21 years and runs a large diabetes service at Leeds Children’s Hospital. England, UK for 450 patients aged 0-20 years.
The Leeds diabetes team has a special interest in the use of technologies and integrating their use into routine clinical practice. 60 % of our patients are using insulin pumps, 30 % using continuous glucose monitoring and over 25% using the Abbott Freestyle Libre system.
Dr Campbell has been the Chair of the National Children and Young Peoples (CYP) Diabetes Network in England & Wales for the last 8 years and believes that this has given her a unique perspective of the national picture in the provision of services and standards of care offered to CYP with diabetes in England and Wales.
Dr Campbell has a particular interest in improving care quality and has been involved in many quality improvement initiatives in Children and Young Peoples diabetes care over the last 10 years. She was involved in discussions leading to the development of the Best Practice Tariff and its introduction to the CYP Diabetes services in England in 2012. She was also the diabetes clinician that originally developed the National Peer Review Quality Assurance Programme for Paediatric Diabetes.
In addition to the above roles she is currently serving on the Council of Healthcare Professionals at Diabetes UK to ensure that the interests of children and young peoples are addressed. She is also CYP Diabetes representative on the NHS England CCG Improvement and Assessment Framework Expert Reference Group, the Diabetes UK Clinical Advisory Group, the ABCD/Diabetes UK Type 1 Right Care pathway development group, Type 1 Diabetes Collaborative and the UK Insulin Pump Network.
Job Title:
Professor of Metabolic Medicine
Organisation
University of Leeds
Biography
Professor Ajjan (MD, FRCP, MMed.Sci, PhD) obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals Trust. Professor Ajjan’s research work covers a spectrum of basic, translational and clinical studies with the common aim of reducing vascular complications in diabetes and reducing morbidity and mortality in this high-risk population. His research group described three novel mechanisms for hypofibrinolysis in diabetes, with both hypo and hyperglycaemia having key roles. Moreover, Professor Ajjan has shown a close relationship between hypoglycaemia and adverse clinical outcome in patients with diabetes.
Given the pathogenic effects of high and low blood glucose levels, he has been involved in a number of studies investigating the role of continuous glucose monitoring in optimising glycaemic control in diabetes. Professor Ajjan’s research work has been published in peer reviewed journals and he has over 100 publications including original papers, reviews and book chapters.
His clinical practice concentrates on complicated type 2 diabetes patients with established cardiovascular disease as well as young adults with diabetes. Professor Ajjan is the R&D lead for Diabetes/Endocrinology at Leeds Teaching Hospitals Trust and the regional clinical research network lead for endocrine and metabolic conditions. He is also the lead for first year medical student teaching in Endocrinology and Diabetes at Leeds University and co-lead of the Atherothrombosis and Diabetes group within Leeds Institute for Cardiovascular and Metabolic Medicine.
Job Title:
Consultant Physician (Diabetes & Endocrinology)
Organisation
Portsmouth Hospitals NHS Trust
Biography
Dr Iain Cranston is a diabetes physician based in Portsmouth, UK. He has specialty responsibility for the delivery of technology-driven services (CSII / CGM etc.) to approximately 1% of the UK population. Alongside this, he is the lead diabetes clinician for the Wessex renal and transplant centre, managing individuals with specific and high glycaemic risks. He has a background in clinical research, obtained during his time at Guy’s and King’s College and St Thomas’ Hospitals, into impaired awareness of hypoglycaemia in insulin-treated diabetes and the cerebral and endocrine mechanisms underlying the syndrome.
For the last 20 years, Dr Cranston has been in practice with the goal of translating the lessons learnt from research into routine clinical care consultations. This has resulted in a focus on effective glucose monitoring strategies to underpin clinical decision-making and the development of data analytical processes to guide clinical consultations towards more effective therapeutic interventions in both type 1 and type 2 diabetes. He has published widely on this topic area (over 60 Peer-reviewed publications) and has been an invited speaker at Diabetes UK, EASD and many National meetings around the world.
For the last 4 years, Dr Cranston has been a co-director in a collaborative educational project with Professor Roger Mazze (International Diabetes Center [IDC] Minnesota), at the AGP Clinical Academy, which has the central goal of educating healthcare professionals in the effective clinical interpretation of the ambulatory glucose profile derived from continuous glucose monitoring technologies.